NCT00676910View on ClinicalTrials.gov

A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

February 28, 2010

Conditions
Neoplasms
Interventions
DRUG

JNJ-26854165

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00676910 - A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. | Biotech Hunter | Biotech Hunter